Literature DB >> 17670840

Mapping and characterization of the primary and anamnestic H-2(d)-restricted cytotoxic T-lymphocyte response in mice against human metapneumovirus.

Guillermina A Melendi1, Fidel Zavala, Ursula J Buchholz, Guy Boivin, Peter L Collins, Steven R Kleeberger, Fernando P Polack.   

Abstract

Cytotoxic T lymphocytes (CTLs) are important for the control of virus replication during respiratory infections. For human metapneumovirus (hMPV), an H-2(d)-restricted CTL epitope in the M2-2 protein has been described. In this study, we screened the hMPV F, G, N, M, M2-1, and M2-2 proteins using three independent algorithms to predict H-2(d) CTL epitopes in BALB/c mice. A dominant epitope (GYIDDNQSI) in positions 81 to 89 of the antitermination factor M2-1 and a subdominant epitope (SPKAGLLSL) in N(307-315) were detected during the anti-hMPV CTL response. Passive transfer of CD8(+) T-cell lines against M2-1(81-89) and N(307-315) protected Rag1(-/-) mice against hMPV challenge. Interestingly, diversification of CTL targets to include multiple epitopes was observed after repetitive infections. A subdominant response against the previously described M2-2 epitope was detected after the third infection. An understanding of the CTL response against hMPV is important for developing preventive and therapeutic strategies against the virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17670840      PMCID: PMC2045518          DOI: 10.1128/JVI.02423-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  Lymphocyte-mediated cytotoxicity.

Authors:  John H Russell; Timothy J Ley
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.

Authors:  P J Openshaw; K Anderson; G W Wertz; B A Askonas
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

Authors:  J A Nicholas; K L Rubino; M E Levely; E G Adams; P L Collins
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.

Authors:  J Chang; A Srikiatkhachorn; T J Braciale
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

Authors:  P Romero; J L Maryanski; G Corradin; R S Nussenzweig; V Nussenzweig; F Zavala
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

6.  Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy.

Authors:  Federico R Laham; Victor Israele; Javier M Casellas; Alejandro M Garcia; Carlos M Lac Prugent; Scott J Hoffman; Debra Hauer; Bhagvanji Thumar; Maria Ivonne Name; Andres Pascual; Natalia Taratutto; Maria T Ishida; Marcela Balduzzi; Miguelina Maccarone; Susana Jackli; Roberto Passarino; Raul A Gaivironsky; Ruth A Karron; Norberto R Polack; Fernando P Polack
Journal:  J Infect Dis       Date:  2004-05-06       Impact factor: 5.226

7.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

8.  The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes.

Authors:  Alexander Bukreyev; Maria Elina Serra; Federico R Laham; Guillermina A Melendi; Steven R Kleeberger; Peter L Collins; Fernando P Polack
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

9.  Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen.

Authors:  J V Spencer; T J Braciale
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

10.  Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections.

Authors:  Sherry R Crowe; Stephen J Turner; Shannon C Miller; Alan D Roberts; Rachel A Rappolo; Peter C Doherty; Kenneth H Ely; David L Woodland
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  19 in total

1.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

Review 2.  Recent vaccine development for human metapneumovirus.

Authors:  J Ren; T Phan; X Bao
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

3.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

Review 4.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

5.  Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.

Authors:  Reagan G Cox; John J Erickson; Andrew K Hastings; Jennifer C Becker; Monika Johnson; Ryan E Craven; Sharon J Tollefson; Kelli L Boyd; John V Williams
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

6.  Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.

Authors:  Sherry C Wen; Jennifer E Schuster; Pavlo Gilchuk; Kelli L Boyd; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

Review 7.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 8.  Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.

Authors:  Andrea E González; Margarita K Lay; Evelyn L Jara; Janyra A Espinoza; Roberto S Gómez; Jorge Soto; Claudia A Rivera; Katia Abarca; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Virulence       Date:  2016-12-02       Impact factor: 5.882

9.  An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats.

Authors:  Hoyin Mok; Sharon J Tollefson; Amy B Podsiad; Bryan E Shepherd; Vasiliy V Polosukhin; Robert E Johnston; John V Williams; James E Crowe
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Viral acute lower respiratory infections impair CD8+ T cells through PD-1.

Authors:  John J Erickson; Pavlo Gilchuk; Andrew K Hastings; Sharon J Tollefson; Monika Johnson; Melissa B Downing; Kelli L Boyd; Joyce E Johnson; Annette S Kim; Sebastian Joyce; John V Williams
Journal:  J Clin Invest       Date:  2012-07-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.